← Back to Search

Smartphone App for Smoking Cessation (OKquit Trial)

N/A
Recruiting
Led By Michael S Businelle, PhD
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 27 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a new smartphone app called OKquit to help smokers quit. It targets smokers who use the Oklahoma Tobacco Helpline and have smartphones. The app provides regular check-ins and personalized messages to support quitting efforts.

Who is the study for?
This trial is for adults in Oklahoma who smoke at least 5 cigarettes a day, are willing to quit within 21 days after starting the study, and can use a smartphone compatible with the Insight mHealth Platform. They must be able to complete daily and weekly surveys for 27 weeks. People with low health literacy (as measured by REALM-SF) or without an Oklahoma address are excluded.
What is being tested?
The study tests a new smoking cessation app called OKquit against Standard Helpline Care provided by the Oklahoma Tobacco Helpline. Participants will either get standard care plus daily check-ins and weekly surveys through an app or this standard care along with additional features from the OKquit app.
What are the potential side effects?
Since this trial involves using smartphone applications for smoking cessation, there aren't typical medical side effects; however, participants may experience stress or frustration if they find it difficult to quit smoking or use the technology.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~27 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 27 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Smoke
Secondary study objectives
Cessation motivation
Treatment engagement

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: The Standard Helpline Care (SC) groupActive Control1 Intervention
The SC group will receive standard Oklahoma Smoking Cessation Helpline care AND complete daily check-ins and weekly surveys for 27 weeks.
Group II: OKquit groupActive Control1 Intervention
The OKquit group will receive SC plus daily check-ins and weekly surveys for 27 weeks. In addition, the OKquit group will receive tailored smoking cessation messages in the smartphone application following completion of each survey. Further, the OKquit group will have access to on-demand smoking cessation content through the app.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for smoking cessation include pharmacologic methods, such as nicotine replacement therapy (NRT) and medications like varenicline and bupropion, which work by reducing withdrawal symptoms and cravings. Behavioral strategies, such as individual counseling, group therapy, and digital interventions like smartphone apps, provide psychological support and coping mechanisms. The OKquit smoking cessation app exemplifies a modern approach by offering tailored messages and on-demand content, which can enhance motivation and provide immediate support during critical moments. These mechanisms are crucial for smoking cessation patients as they address both the physical dependence on nicotine and the behavioral aspects of smoking, increasing the likelihood of successful quitting.
An international survey: Tobacco smoking cessation strategies within left ventricular assist device centers.Mobile phone-based messaging for tobacco cessation in low and middle-income countries: A systematic review.The natural history of efforts to stop smoking: a prospective cohort study.

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor
471 Previous Clinical Trials
92,953 Total Patients Enrolled
Michael S Businelle, PhDPrincipal InvestigatorUniversity of Oklahoma
1 Previous Clinical Trials
453 Total Patients Enrolled

Media Library

OKquit Clinical Trial Eligibility Overview. Trial Name: NCT05539209 — N/A
Smoking Cessation Research Study Groups: The Standard Helpline Care (SC) group, OKquit group
Smoking Cessation Clinical Trial 2023: OKquit Highlights & Side Effects. Trial Name: NCT05539209 — N/A
OKquit 2023 Treatment Timeline for Medical Study. Trial Name: NCT05539209 — N/A
~109 spots leftby Jun 2025